ArticleHealth science reports2025
Prevalence of Precancerous Cervical Lesion and Its Associated Factors Among HIV/AIDS Positive and Negative Women in Debre Berhan Comprehensive Specialized Hospital, North Shewa Zone, Amhara Regional State, Ethiopia: A Cross-Sectional Study.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Precancerous Cervical Lesions in HIV-Positive Women: Caution Needed in Interpreting Low Prevalence Estimates.Health science reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pre-invasive cervical lesion typically progresses for a considerable amount of time before developing into cervical cancer (CC). Consequently, early detection and treatment of cervical cancer at the pre-invasive stage may be advantageous to the patients and lessen the burden of morbidity and mortality from the disease. Our country has limited studies on Precancerous Cervical Lesions (PCCL). Aims: To assess the prevalence and associated factors of precancerous cervical lesions among HIV-positive and negative women in Debre Birhan Comprehensive Specialized Hospital, Ethiopia. Methods: An institutional-based comparative cross-sectional study was conducted from July/2021 to June/2023 among 522 women attending cervical cancer screening at Debre Birhan Comprehensive Specialized Hospital. All records during the study period were collected using a structured data extraction checklist. Binary logistic regression analyses were conducted to identify factors associated with pre-cancerous cervical lesions. Results: The overall prevalence of pre-cancerous cervical lesions was 8% (95% CI: 5.6-10.5. The prevalence of pre-cancerous cervical lesions in HIV-positive was 5.4% (95% CI: 2.8-.1) and in HIV-negative women 10.7% (95% CI: 5.6-8.1). Women with lifetime sexual partner ≥ 2 (AOR = 3.84, 95% CI: 1.06-3.97), who have a history of STI (AOR = 5.66, 95% CI: 1.50-21.41) and women with age ≥ 45 years (AOR = 4.22, 95% CI: 1.21-14.76) were contributing factors of a PCCL for HIV-positive women. In addition, women with a history of Sexually Transmitted Infection (STI) (AOR = 6.51, 95% CI: 2.11-0.09) and who have a lifetime sexual partner ≥ 2 (AOR = 8.4, 95% CI: 2.85-4.79) were statistically significant association with pre-cancerous cervical lesion for HIV-negative women. Conclusion: The overall prevalence of pre-cancerous cervical lesions was found to be low in this study relative to the national prevalence. However, strengthening routine screening of women for pre-cancerous cervical lesions and behavioural change communication on risk factors is very important.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.